Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampin and Azithromycin for Onchocerciasis
NCT00127504Phase 2Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of rifampicin and azithromycin in onchocerciasis (4 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoint: Eliminating Wolbachia endobacteria present in O. volvulus worms at 9 months. Started Jul 2003; status: completed.
02
Drugs
rifampicinazithromycin
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on NCT00127504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127504.